Skip to main content
. 2017 May 8;8(31):51859–51868. doi: 10.18632/oncotarget.17700

Table 3. Genotype and allele frequencies of the HAMP gene in controls and patients with Kawasaki disease.

Genotype Case (%) (n =381) Control cohort 1 (%) (n= 497) Control cohort 2 (%) (n =500) Cohort 1 Recessive P Value Allelic P Value Cohort 2 Recessive P Value Allelic P Value
rs916145 CC 46 (13.1) 60 (12.2) 71 (14.2) 0.7108 0.6652 0.6481 0.4768
CG 158 (45.0) 219 (44.7) 231 (46.2)
GG 147 (41.9) 211 (43.1) 198 (39.6)
rs10421768 GG 0 (0.0) 0 (0.0) 0 (0.0) 1.0000 0.3270 1.000 0.4533
AG 3 (0.8) 8 (1.6) 7 (1.4)
AA 354 (99.2) 489 (98.4) 493 (98.6)
rs3817623 TT 2 (0.6) 2 (0.5) 1 (0.2) 0.8828 0.3129 03745 0.9983
GT 30 (8.5) 45 (11.0) 46 (9.2)
GG 322 (90.9) 363 (88.5) 453 (90.6)
rs7251432 GG 67 (18.8) 77 (16.1) 67 (13.4) 0.3120 0.1672 0.0315* 0.0939
AG 163 (45.8) 212 (44.5) 243 (48.6)
AA 126 (35.4) 188 (39.4) 190 (38.0)
rs2293689 TT 2 (0.6) 4 (1.3) 2 (0.4) 0.3333 0.0410* 0.7366 0.8016
CT 44 (12.3) 54 (17.0) 60 (12.0)
CC 312 (87.1) 260 (81.7) 438 (87.6)

*Significant (P < 0.05) values are in bold.